Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VORINOSTAT vs VORTIOXETINE HYDROBROMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VORINOSTAT vs VORTIOXETINE HYDROBROMIDE: Safety Overview

Metric VORINOSTAT VORTIOXETINE HYDROBROMIDE
Total FAERS Reports 1,246 13,705
Deaths Reported 239 400
Death Rate 19.2% 2.9%
Hospitalizations 490 1,741
Average Patient Age 47.8 yrs 48.8 yrs
% Female Patients 46.3% 69.5%
FDA Approval Date Oct 6, 2006 Sep 30, 2013
Manufacturer Merck Sharp & Dohme LLC Takeda Pharmaceuticals America, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription